Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
EMBO Mol Med ; 14(8): e15888, 2022 08 08.
Article in English | MEDLINE | ID: covidwho-1918174

ABSTRACT

Durable cell-mediated immune responses require efficient innate immune signaling and the release of pro-inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS-CoV-2 mRNA vaccination primes human monocyte-derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3-driven pyroptotic cell death and subsequently secrete mature interleukin-1ß. These effects depend on activation of spleen tyrosine kinase (SYK) coupled to C-type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage-driven activation of effector memory T cells. Furthermore, vaccination-induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime-boost concepts to augment innate immune signaling in SARS-CoV-2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate spike protein-specific T cell responses.


Subject(s)
COVID-19 , NLR Family, Pyrin Domain-Containing 3 Protein , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Immunity, Innate , Inflammasomes/metabolism , Interleukin-1beta , Intracellular Signaling Peptides and Proteins/genetics , Protein-Tyrosine Kinases/metabolism , RNA, Messenger/genetics , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/genetics , Syk Kinase , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL